Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 2/20 | 0.32 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.30 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.30 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29051906 | 0.77 | APEX1 (0.35) | AKR1B1 | |
| SCHEMBL2490028 | 0.70 | AKR1B1 (0.39) | AKR1B1 | |
| SCHEMBL29089254 | 0.69 | ALPI (0.39) | KIF11 | |
| SCHEMBL14840086 | 0.69 | ALPI (0.39) | KIF11 | |
| SCHEMBL5668472 | 0.69 | ALDH1A1 (0.38) | AKR1B1 | |
| SCHEMBL28472018 | 0.69 | HTT (0.34) | AKR1B1 | |
| SCHEMBL30625890 | 0.68 | SLC7A5 (0.41) | KIF11 | |
| Hydrochloric Acid SCHEMBL27357806 | 0.67 | TSHR (0.35) | — | |
| SCHEMBL20362157 | 0.67 | APEX1 (0.33) | AKR1B1 | |
| SCHEMBL24495475 | 0.66 | TDP1 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0817621-A1 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY | SANOFI (FR) | 1998-01-14 | — | — | EP | disclosed |
| WO-1996030000-A1 | PHARMACEUTICAL COMPOSITION FOR TRANSDERMIC DELIVERY | SANOFI (FR) | 1996-10-03 | — | — | WO | disclosed |